A Case of Recalcitrant Psoriatic Arthritis to TNF Inhibitors Improved After Administration of Secukinumab, an IL-17A Inhibitor

Psoriatic arthritis (PsA) is a unique inflammatory arthritis due to the fact that patients have to deal not only with pain but also with their skin appearance, which may have a detrimental effect on their everyday lives and psychology. Treating a patient with PsA, improving both the musculoskeletal...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelechas, Eleftherios, Memi, Tereza, Voulgari, Paraskevi V., Drosos, Alexandros A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696296/
https://www.ncbi.nlm.nih.gov/pubmed/29022197
http://dx.doi.org/10.1007/s40744-017-0084-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696296/
https://www.ncbi.nlm.nih.gov/pubmed/29022197
http://dx.doi.org/10.1007/s40744-017-0084-0

Ejemplares similares